International Journal of Clinical Pharmacy

, Volume 36, Issue 6, pp 1138–1140 | Cite as

Neuropsychiatric symptoms accompanying thrombocytopenia following pregabalin treatment for neuralgia: a case report

  • Caihong QuEmail author
  • Yang Xie
  • Feng Qin
  • Weimin Liu
Case Report


Case description

A 28-year-old female patient developed an increased temperature and neuropsychiatric symptoms after receiving 75 mg pregabalin therapy for neuralgia. She presented initially with pyrexia and dizziness, followed by disorganized speech within an acute confusional state. Her body temperature returned to normal after taking 60 mg loxoprofen sodium several hours later. However, the neuropsychiatric symptoms did not improve until the next morning. Routine blood tests showed decreased platelet counts (from 131 × 109/L to 85 × 109/L). The following day, a further dose of 75 mg pregabalin was administered because of its effective amelioration of the patient’s neuralgia. One hour later, the same symptoms appeared as had previously including increased body temperature of 39.2 °C accompanied by a lower platelet count (73 × 109/L).


Clinicians should be alert to the serious neuropsychiatric symptoms and thrombocytopenia associated with the use of pregabalin. Routine blood tests may be necessary upon initiation of pregabalin treatment.


Adverse drug reaction Neuropsychiatric symptoms Pregabalin Thrombocytopenia 




Conflicts of interest

The authors declare no conflicts of interest.


  1. 1.
    Shneker BF, McAulev JM. Pregabalin: a new neuromodulator with broad therapeutic indications. Ann Pharmacother. 2005;39(12):2029–37.PubMedCrossRefGoogle Scholar
  2. 2.
    Ogawa S, Satoh J, Arakawa A, Yoshiyama T, Suzuki M. Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west. Drug Saf. 2012;35(10):793–806.PubMedCrossRefGoogle Scholar
  3. 3.
    Joshi I, Taylor CP. Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha 2-delta subunit reduces neurotransmission in mice. Eur J Pharmacol. 2006;553(1–3):82–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Guzelkucuk U, Duman I, Yılmaz B, Tan AK. Reversible post-pregabalin peripheral edema in a spinal cord injury patient. Spinal Cord. 2012;50(6):472–3.PubMedCrossRefGoogle Scholar
  5. 5.
    Smith TL, Baldwin A, Cunningham LL Jr, Cook AM. Rash associated with pregabalin use. Ann Pharmacother. 2008;42(12):1899–902.PubMedCrossRefGoogle Scholar
  6. 6.
    Aksakal E, Bakirci EM, Emet M, Uzkeser M. Complete atrioventricular block due to overdose of pregabalin. Am J Emerg Med. 2012;30(9):2101.e1–4.Google Scholar
  7. 7.
    Sendra JM, Junyent TT, Pellicer MJ. Pregabalin-induced hepatotoxicity. Ann Pharmacother. 2011;45(6):e32.PubMedCrossRefGoogle Scholar
  8. 8.
    Bamanikar A, Dhobale S, Lokwani S. Pregabalin hypersensitivity in a patient treated for postherapeutic neuralgia. Indian J Pharmacol. 2013;45(5):522–3.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.PubMedCrossRefGoogle Scholar
  10. 10.
    Okur M, Kaya A, Çaksen H, Taşkın G. Lamotrigine-associated thrombocytopenia and leukopenia. J Emerg Med. 2012;42(5):584–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Köse G, Arhan E, Unal B, Ozaydin E, Guven A, Sayli TR. Valproate-associated coagulopathies in children during short-term treatment. J Child Neurol. 2009;24(12):1493–8.PubMedCrossRefGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2014

Authors and Affiliations

  1. 1.Department of Clinical Pharmacythe Third Affiliated Hospital of Sun Yat-sen UniversityGuangzhouChina
  2. 2.Department of Dermatologythe Third Affiliated Hospital of Sun Yat-sen UniversityGuangzhouChina
  3. 3.Department of Neurologythe Third Affiliated Hospital of Sun Yat-sen UniversityGuangzhouChina
  4. 4.Department of Radiologythe Third Affiliated Hospital of Sun Yat-sen UniversityGuangzhouChina

Personalised recommendations